Pandemic threat posed by avian influenza A viruses

Clinical Microbiology Reviews

Volumn 14, Issue 1, 2001, Pages 129-149

  Horimoto, T ^a   Kawaoka, Y ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; INFLUENZA VIRUS HEMAGGLUTININ; PROTEINASE; VIRUS PROTEIN; ZANAMIVIR;

ANIMAL CELL; ANTIGENICITY; EPIDEMIC; FOWL; HONG KONG; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A; NONHUMAN; PATHOGENICITY; PHYLOGENY; PROTEIN DEGRADATION; REVIEW; VIRUS INFECTION; VIRUS LOAD; VIRUS TRANSMISSION; VIRUS VIRULENCE;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; DISEASE OUTBREAKS; DISEASE VECTORS; HONG KONG; HUMANS; INFLUENZA A VIRUS; INFLUENZA IN BIRDS; INFLUENZA, HUMAN; MEXICO; PENNSYLVANIA; POULTRY; VIRAL PROTEINS; VIRULENCE;

ANIMALIA; AVES; AVIAN INFLUENZA VIRUS; GALLIFORMES; GALLUS GALLUS; INFLUENZA A VIRUS; INFLUENZA VIRUS; INFLUENZAVIRUS A; MAMMALIA;

EID: 0035137605     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.14.1.129-149.2001     Document Type: Review

References (223)

1. An outbreak of highly pathogenic avian influenza in turkeys in Great Britain in 1991
2. Experimental assessment of the pathogenicity of eight avian influenza A viruses of H5 subtype for chickens, turkeys, ducks and quail
3. A single gene determines the host range of influenza virus
4. Antigenic mapping of an avian H1 influenza virus haemagglutinin and interrelationships of H1 viruses from humans, pigs and birds
5. Characterisation of an avian influenza A virus isolated from a human - Is an intermediate host necessary for the emergence of pandemic influenza viruses?
6. Mammalian subtilisins: The long-sought dibasic processing endoproteases
7. Molecular pathotyping of two avian influenza viruses isolated during the Victoria 1976 outbreak
8. The N2 neuraminidase of human influenza virus has acquired a substrate specificity complementary to the hemagglutinin receptor specificity
9. Recombination of human influenza A viruses in nature
10. Characterization of virulent and avirulent A/Chicken/Pennsylvania/83 influenza A viruses: Potential role of defective interfering RNAs in nature
11. Evolution of the H3 influenza virus hemagglutinin from human and nonhuman hosts
12. Biologic potential of amantadine-resistant influenza A virus in an avian model
13. Emergence of amantadine-resistant H5N2 avian influenza virus during a simulated layer flock treatment program
14. Replication of avian influenza viruses in humans
15. The isolation and classification of tern virus: Influenza virus A/Tern/South Africa/61
16. Mouse neurotropic recombinants of influenza A viruses
17. Proteolytic cleavage of influenza virus hemagglutinins: Primary structure of the connecting peptide between HA1 and HA2 determines proteolytic cleavability and pathogenicity of avian influenza viruses
18. The structure of the hemagglutinin, a determinant for the pathogenicity of influenza viruses
19. l sites
20. Isolation of an influenza A virus of unusual subtype (H1N7) from pigs in England, and the subsequent experimental transmission from pig to pig
21. Genetic characterisation of an influenza A virus of unusual subtype (H1N7) isolated from pigs in England
22. Recovery of minority subpopulation of highly pathogenic avian influenza virus
23. Structure of influenza haemagglutinin at the pH of membrane fusion
24. Influenza virus on the developing egg
25. New approaches to influenza chemotherapy - Neuraminidase inhibitors
26. The appearance of H3 influenza viruses in seals
27. Fowl plague virus from man
28. Antigenic and sequence analysis of H3 influenza virus haemagglutinins from pigs in Italy
29. Genetic reassortment between avian and human influenza A viruses in Italian pigs
30. Biologic importance of neuraminidase stalk length in influenza A virus
31. Update. Isolation of avian influenza A (H5N1) viruses from humans - Hong Kong, 1997-1998
32. Antigenic and molecular characterization of subtype H13 hemagglutinin of influenza virus
33. Infection of children with avian-human reassortant influenza virus from pigs in Europe
34. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus
35. Origin and progress of the 1968-1969 Hong Kong influenza epidemic
36. The three-dimensional structure of a complex of influenza virus neuraminidase and an antibody
37. Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates
38. Influenza virus strains selectively recognize sialyloligosaccharides on human respiratory epithelium: The role of the host cell in selection of hemagglutinin receptor specificity
39. The status of avian influenza in poultry in Australia
40. Glycosylation affects cleavage of an H5N2 influenza virus hemagglutinin and regulates virulence
41. Distinct lineages of influenza virus H4 hemagglutinin genes in different regions of the world
42. Influenza
43. Avian influenza in Pennsylvania: The beginning
44. An 18 amino acid deletion in an influenza neuraminidase
45. Introduction of site-specific mutations into the genome of influenza virus
46. Specification of receptor-binding phenotypes of influenza virus isolates from different hosts using synthetic sialylglycopolymers: Non-egg-adapted human H1 and H3 influenza A and influenza B viruses share a common high binding affinity for 6′-sialyl(N-acetyllactosamine)
47. Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from humans in Hong Kong
48. Heterogeneity in the haemagglutinin gene and emergence of the highly pathogenic phenotype among recent H5N2 avian influenza viruses from Mexico
49. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems
50. Understanding influenza virus pathogenicity
51. Mass mortality of harbor seals: Pneumonia associated with influenza A virus
52. Evolution of influenza A virus nucleoprotein genes: Implications for the origins of H1N1 human and classical swine viruses
53. Mutations affecting the sensitivity of the influenza virus neuraminidase to 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid
54. A novel mechanism for the acquisition of virulence by a human influenza A virus
55. An endoprotease homologous to the blood clotting factor X as a determinant of viral tropism in chick embryo
56. The specific enzyme of influenza virus and Vibrio cholerae
57. Influence of amantadine resistance mutations on the pH regulatory function of the M2 protein of influenza A viruses
58. Emergence of avian H1N1 influenza viruses in pigs in China
59. Molecular characterization of H9N2 influenza viruses: Were they the donors of the "internal" genes of H5N1 viruses in Hong Kong?
60. Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus
61. Characterization of influenza A/HongKong/156/97 (H5N1) virus in a mouse model and protective effect of zanamivir on H5N1 infection in mice
62. A H1 hemagglutinin of a human influenza A virus with a carbohydrate-modulated receptor binding site and an unusual cleavage site
63. Characterization of a new avian-like influenza A virus from horses in China
64. Seroepidemiological and molecular evidence for the presence of two H3N8 equine influenza viruses in China in 1993-1994
65. Human influenza A (H1N2) viruses isolated from China
66. The molecular basis of the specific anti-influenza action of amantadine
67. Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine
68. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infections
69. Characterization of two influenza A viruses from a pilot whale
70. Are seals frequently infected with avian influenza viruses?
71. Genetic reassortment of influenza A viruses in the intestinal tract of ducks
72. Altered tissue tropism of human-avian reassortant influenza viruses
73. The perpetuation of orthomyxoviruses and paramyxoviruses in Canadian waterfowl
74. Agglutination of red cells by allantoic fluid of chick embryos infected with influenza virus
75. Reverse genetics provides direct evidence for a correlation of hemagglutinin cleavability and virulence of an avian influenza A virus
76. Molecular changes in virulent mutants arising from avirulent avian influenza viruses during replication in 14-day-old embryonated eggs
77. Proprotein-processing endoproteases PC6 and furin both activate hemagglutinin of virulent avian influenza viruses
78. Origin and molecular changes associated with emergence of a highly pathogenic H5N2 influenza virus in Mexico
79. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential
80. Perpetuation of influenza A viruses in Alaskan waterfowl reservoirs
81. Differences in sialic acid-galactose linkages in the amnion and allantois of chicken eggs influence human influenza virus receptor specificity and varian selection
82. Epidemiologic studies of the 1975 avian influenza outbreak in chickens in Alabama
83. WHO coordinated research on the role of animals in influenza epidemiology: Introduction
84. Structural features influencing hemagglutinin cleavability in a human influenza A virus
85. Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics
86. Is virulence of H5N2 influenza viruses in chickens associated with loss of carbohydrate from the hemagglutinin?
87. Molecular analyses of the hemagglutinin genes of H5 influenza viruses: Origin of a virulent turkey strain
88. Evolution of the A/Chicken/Pennsylvania/83 (H5N2) influenza virus
89. Molecular mechanism of acquisition of virulence in influenza virus in nature
90. Sequence requirements for cleavage activation of influenza virus hemagglutinin expressed in mammalian cells
91. Interplay between carbohydrate in the stalk and the length of the connecting peptide determines the cleavability of influenza virus hemagglutinin
92. Molecular characterization of a new hemagglutinin, subtype H14, of influenza A virus
93. Increased viral pathogenicity after insertion of a 28S ribosomal RNA sequence into the haemagglutinin gene of an influenza virus
94. Potential for transmission of avian influenza viruses to pigs
95. Antigenic and genetic conservation of H3 influenza in wild ducks
96. Origin of the hemagglutinin gene of H3N2 influenza viruses from pigs in China
97. Duck influenza lacking evidence of disease signs and immune response
98. Isolation and characterization of a novel trypsin-like protease found in rat bronchiolar epithelial Clara cells. A possible activator of the viral fusion glycoprotein
99. Host cell proteases controlling virus pathogenicity
100. The molecular biology of influenza virus pathogenicity
101. Activation of influenza A viruses by trypsin treatment
102. An avian influenza A virus killing a mammalian species - The mink
103. Amino acid residues contributing to the substrate specificity of the influenza A virus neuraminidase
104. Pathological studies of chickens experimentally infected with two highly pathogenic avian influenza viruses
105. Are the 5′ ends of influenza viral mRNAs synthesized in vivo donated by host mRNAs?
106. Influenza in 1977: Recurrence of influenza virus A subtype H1N1
107. Avian influenza virus isolated from a woman with conjunctivitis
108. Orthomyxoviridae: The viruses and their replication
109. Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide
110. Recombinant influenza A virus vaccines for the pathogenic human A Hong Kong 97 (H5N1) viruses
111. A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans
112. Comparison of influenza viruses isolated from man and from whales
113. Nuclear transport of influenza virus ribonucleoproteins: The viral matrix protein (M1) promotes export and inhibits import
114. Influenza vaccine virus strains chosen
115. The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties
116. Avian influenza a viruses differ from human viruses by recognition of sialyloligosaccharides and gangliosides and by a higher conservation of the HA receptor-binding site
117. Experimental infection of mink with influenza A viruses
118. Comparative pathology of chickens experimentally inoculated with avian influenza viruses of low and high pathogenicity
119. Human furin is a calcium-dependent serin endoprotease that recognize the sequence Arg-X-X-Arg and efficiently cleaves anthrax toxin protective antigen
120. Case-control study of risk factors for avian influenza A (H5N1) disease, Hong Kong, 1997
121. Two signals mediate nuclear localization of influenza virus (A/WSN/33) polymerase basic protein 2
122. Evaluation of the A/Seal/Mass/1/80 virus in squirrel monkeys
123. Virulence of avian influenza A viruses for squirrel monkeys
124. Orthomyxoviruses
125. Mutations in the hemagglutinin receptor-binding site can change the biological properties of an influenza virus
126. Recent human influenza A (H1N1) viruses are closely related genetically to strains isolated in 1950
127. Furin: A mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins
128. Function of two discrete regions is required for nuclear localization of polymerase basic protein 1 of A/WSN/33 influenza virus (HIN1)
129. Genetic analysis of porcine H3N2 viruses originating in southern China
130. Molecular analysis of the hemagglutinin genes of Australian H7N7 influenza viruses: Role of passerine birds in maintenance or transmission?
131. Nuclear import and export of influenza virus nucleoprotein
132. Genes involved in the virulence of an avian influenza virus
133. Mutations at the cleavage site of the hemagglutinin alter the pathogenicity of influenza virus A/chick/Penn/83 (H5N2)
134. Human influenza virus hemagglutinin with high sensitivity to proteolytic activation
135. Contact infection of mink with 5 subtypes of avian influenza virus
136. The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins
137. Nonhomologous recombination between the hemagglutinin gene and the nucleoprotein gene of an influenza virus
138. Characterization of temperature-sensitive influenza virus mutants defective in neuraminidase
139. Interactions of animal viruses with cell surface receptors
140. Influenza A H9N2: Aspects of laboratory diagnosis
141. Evidence for the natural transmission of influenza A virus from wild ducks to swine and its potential importance for man
142. An Arg-Lys insertion at the hemagglutinin cleavage site of an H5N2 avian influenza isolate
143. Virulence-associated sequence duplication at the hemagglutinin cleavage site of avian influenza viruses
144. Epizoozia tifoide nei gallinacei
145. 2 protein has ion channel activity
146. A unique cap (m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription
147. The nature of avian influenza in turkeys in Minnesota
148. Chronicle of influenza pandemics
149. Influenza diffusion in European history: Patterns and paradigms
150. Origin and evolution of the 1918 "Spanish" influenza virus hemagglutinin gene
151. NS2 protein of influenza virus is found in purified virus and phosphorylated in infected cells
152. Evolutionary conserved close linkage of the c-fes/fps proto-oncogene and genetic sequences encoding a receptor-like protein
153. Receptor binding properties of human and animal H1 influenza virus isolates
154. Receptor determinants of human and animal influenza virus isolates: Differences in receptor specificity of the H3 hemagglutinin based on species of origin
155. Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity
156. Differential sensitivity of human, avian, and equine influenza A viruses to a glycoprotein inhibitor of infection: Selection of receptor specific variants
157. Different hemagglutinin cleavage site variants of H7N7 in an influenza outbreak in chickens in Leipzig, Germany
158. Characterization of a novel influenza hemagglutinin, H15: Criteria for determination of influenza A subtypes
159. Influenza viruses, cell enzymes, and pathogenicity
160. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays
161. Emergence of a potentially pathogenic H5N2 influenza virus in chickens
162. Origin of the pandemic 1957 H2 influenza A virus and the persistence of its possible progenitors in the avian reservoir
163. Sero-immunologic studies on incomplete forms of the virus of classical fowl plague (German)
164. Interactions between bacteria and influenza A virus in the development of influenza pneumonia
165. Genetic relatedness of hemagglutinins of the H1 subtype of influenza A viruses isolated from swine and birds
166. The nucleoprotein as a possible major factor in determining host specificity of influenza H3N2 viruses
167. Host-range recombinants of fowl plague (influenza A) virus
168. Fish farming and influenza pandemics
169. On the origin of the human influenza virus subtype H2N2 and H3N2
170. Genetic relatedness between the new 1977 epidemic strains (H1N1) of influenza and human influenza strains isolated between 1947 and 1957
171. Eukaryotic protein processing: Endoproteolysis of precursor proteins
172. Survey of the hemagglutinin (HA) cleavage site sequence of H5 and H7 avian influenza viruses: Amino acid sequence at the HA cleavage site as a marker of pathogenicity potential
173. Influenza virus RNA replication in vitro: Synthesis of viral template RNAs and virion RNAs in the absence of an added primer
174. An influenza epicenter?
175. Characterization of avian H5N1 influenza viruses from poultry in Hong Kong
176. Type-A influenza viruses isolated from wild free-flying ducks in California
177. A virus obtained from influenza patients
178. The avian influenza virus nucleoprotein gene and a specific constellation of avian and human virus polymerase genes each specify attenuation of avian/human influenza A/Pintail/79 reassortant viruses from monkeys
179. Role of hemagglutinin cleavage for the pathogenicity of influenza virus
180. Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease
181. Comparisons of highly virulent H5N1 influenza A viruses isolated from humans and chickens from Hong Kong
182. A single amino acid in the PB2 gene of influenza A virus is a determinant of host range
183. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness
184. Gangliosides as influenza virus receptors. Variation of influenza viruses and their recognition of the receptor sialo-sugar chains
185. Single-aminoacid substitution in an antigenic site of influenza virus hemagglutinin can alter the specificity of binding to cell membrane-associated gangliosides
186. Pathogenicity and diagnosis of H5N2 Mexican avian influenza viruses in chickens
187. Influenza virus M2 protein ion channel activity stabilizes the native form of fowl plague virus hemagglutinin during intracellular transport
188. Role of staphylococcus protease in the development of influenza pneumonia
189. Initial genetic characterization of the 1918 "Spanish" influenza virus
190. Plaque assay and primary isolation of influenza A viruses in an established line of canine kidney cells (MDCK) in the presence of trypsin
191. The B allele of the NS gene of avian influenza viruses, but not the A allele, attenuates a human influenza A virus for squirrel monkeys
192. Hemagglutinin activation of pathogenic avian influenza viruses of serotype H7 requires the protease recognition motif R-X-K/R-R
193. Rational design of potent sialidase-based inhibitors of influenza virus replication
194. Sequence specificity of furin, a proprotein-processing endoprotease, for the hemagglutinin of a virulent avian influenza virus
195. Location and character of the cellular enzyme that cleaves the hemagglutinin of a virulent avian influenza virus
196. The NPI-1/NPI-3 (Karyopherin α) binding site on the influenza A virus nucleoprotein NP is a nonconventional nuclear localization signal
197. Expression and analysis of the NS2 protein of influenza A virus
198. Are equine 1 influenza viruses still present in horses?
199. Influenza virus: Transmission between species and relevance to emergence of the next human pandemic
200. Evolution and ecology of influenza A viruses
201. Conjunctivitis in human beings caused by influenza A virus of seals
202. Characterization of an influenza A virus from seals
203. Avian influenza
204. Chemotherapy and vaccination: A possible strategy for the control of highly virulent influenza virus
205. Molecular changes in A/Chicken/Pennsylvania/83 (H5N2) influenza virus associated with acquisition of virulence
206. Antigenic variation of influenza viruses
207. Molecular mechanisms of variation in influenza viruses
208. Protection against lethal influenza with neuraminidase
209. Intestinal influenza: Replication and characterization of influenza viruses in ducks
210. Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid
211. Swine influenza virus infections. Transmission from ill pigs to humans at a Wisconsin agricultural fair and subsequent probable person-to-person transmission
212. Membrane fusion activity of influenza virus
213. The structure and function of the hemagglutinin membrane glycoprotein of influenza virus
214. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation
215. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3A resolution
216. Deduced amino acid sequences of the haemagglutinin of H5N1 avian influenza virus isolates from an outbreak in turkeys in Norfolk
217. Deduced amino acid sequences at the haemagglutinin cleavage site of avian influenza A viruses of H5 and H7 subtypes
218. Genetic characterization of the pathogenic influenza A/Goose/Guangdong/1/96 (H5N1) virus: Similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong
219. Molecular assembly of influenza virus: Association of the NS2 protein with virion matrix
220. Evolution of human influenza A viruses in nature. Recombination contributes to genetic variation of H1N1 strains
221. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus
222. Influenza A virus M2 protein: Monoclonal antibody restriction of virus growth and detection of M2 in virions